Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in North Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in North Carolina
| Provider | Medicare | Services |
|---|---|---|
| Laboratory Corporation Of America... | $45.40 | 18.7K |
| Quest Diagnostics Clinical... | $45.42 | 1.5K |
| Fedor, Elana MD | $45.42 | 45 |
| Laboratory Corporation Of America... | $45.42 | 43 |
North Carolina Pricing in Context
In North Carolina, CPT code G0472 (Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s)) carries an average Medicare payment of $45.40 — 1% above the national benchmark of $44.86. 54 providers across the state submitted claims for this procedure in 2023, performing 20.4K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in North Carolina is $113.19, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in North Carolina lands near $98.97, with self-pay cash prices typically around $65.17. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost in North Carolina?
The average Medicare payment for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in North Carolina is $45.40, which is 1% above the national average of $44.86. Providers in NC typically bill $113.19 for this procedure.
What does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost with insurance in North Carolina?
With commercial insurance in North Carolina, Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs an estimated $98.97. Without insurance, the estimated cash price is $65.17. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in North Carolina?
54 providers in North Carolina billed Medicare for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in 2023, performing 20.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cheaper in North Carolina than the national average?
No — Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs 1% above the national average in North Carolina. The state average Medicare payment is $45.40 compared to $44.86 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.